<code id='129171642B'></code><style id='129171642B'></style>
    • <acronym id='129171642B'></acronym>
      <center id='129171642B'><center id='129171642B'><tfoot id='129171642B'></tfoot></center><abbr id='129171642B'><dir id='129171642B'><tfoot id='129171642B'></tfoot><noframes id='129171642B'>

    • <optgroup id='129171642B'><strike id='129171642B'><sup id='129171642B'></sup></strike><code id='129171642B'></code></optgroup>
        1. <b id='129171642B'><label id='129171642B'><select id='129171642B'><dt id='129171642B'><span id='129171642B'></span></dt></select></label></b><u id='129171642B'></u>
          <i id='129171642B'><strike id='129171642B'><tt id='129171642B'><pre id='129171642B'></pre></tt></strike></i>

          focus

          focus

          author:Wikipedia    Page View:88
          ASH19 CAR-T
          Victor Segura Ibarra and Rita Serda, Ph.D., NCI, NIH

          The Food and Drug Administration on Wednesday approved a futuristic new approach to treating cancer, clearing a Novartis therapy that has produced unprecedented results in patients with a rare and deadly cancer. The price tag: $475,000 for a course of treatment.

          That sounds staggering to many patients — but it’s far less than analysts expected.

          advertisement

          The therapy, called a CAR-T, is made by harvesting patients’ white blood cells and rewiring them to home in on tumors. Novartis’s product is the first CAR-T therapy to come before the FDA, leading a pack of novel treatments that promise to change the standard of care for certain aggressive blood cancers.

          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

          GET STARTED Log In

          Wikipedia

          Jerome Adams on the need for new antivirals for Covid
          Jerome Adams on the need for new antivirals for Covid

          PaxlovidtabletsamplesbeinginspectedinFreiburg,Germany.PfizerviaAPTheU.S.Covid-19Public HealthEmergen

          read more
          Russians and Belarusians back at Wimbledon as war in Ukraine continues
          Russians and Belarusians back at Wimbledon as war in Ukraine continues

          VictoriaAzarenkaofBelarusplaysareturntoChina'sYuanYueduringthefirstroundwomen'ssinglesmatchondayoneo

          read more
          Walensky prepares to leave CDC — and Congress — behind
          Walensky prepares to leave CDC — and Congress — behind

          OutgoingCDCDirectorRochelleWalenskyJIMWATSON/AFPviaGettyImagesRochelleWalensky,theoutgoingdirectorof

          read more

          Insurer loopholes limit power of law against surprise medical bills

          AdobeYou’rereadingthewebversionofHealthCareInc., STAT’sweeklynewsletter followingtheflowofmoneyinmed